Search research articles
Contact Us
Filters
Showing results (81-90 of 121) with videos related to
Page
of 13
Sort By:
Nature Communications
|
October 16, 2020
Health and disease markers correlate with gut microbiome composition across thousands of people
Ohad Manor, Chengzhen L Dai, Sergey A Kornilov, et al.
European Journal of Immunology
|
May 22, 2008
IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
David Polchert, Justin Sobinsky, Gw Douglas, et al.
Journal of Viral Hepatitis
|
July 23, 2009
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B
R G Gish, T-T Chang, C-L Lai, et al.
Radiation Research
|
November 16, 2018
Specific Members of the Gut Microbiota are Reliable Biomarkers of Irradiation Intensity and Lethality in Large Animal Models of Human Health
Franck Carbonero, Alba Mayta, Mathilde Bolea, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine
|
June 16, 2000
HIV as a chronic disease: implications for long-term care at an AIDS-dedicated skilled nursing facility
P A Selwyn, J L Goulet, S Molde, et al.
The Journal of Infectious Diseases
|
May 1, 1996
Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia
B P Griffith, H Brett-Smith, G Kim, et al.
International Journal of Radiation Biology
|
September 10, 2020
The New Zealand white rabbit animal model of acute radiation syndrome: hematopoietic and coagulation-based parameters by radiation dose following supportive care
Andre Paredes, Matthew Lindeblad, Rachana Patil, et al.
Journal of Hepatology
|
December 17, 2008
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy
Daniel Shouval, Ching-Lung Lai, Ting-Tsung Chang, et al.
Journal of Viral Hepatitis
|
May 22, 2009
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B
T-T Chang, Y-C Chao, V V Gorbakov, et al.
AIDS (London, England)
|
August 30, 2008
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
Mário Guimarães Pessôa, Brian Gazzard, Anna K Huang, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 121) with videos related to
Sort By:
Page
of 13
Nature Communications
|
October 16, 2020
Health and disease markers correlate with gut microbiome composition across thousands of people
Ohad Manor, Chengzhen L Dai, Sergey A Kornilov, et al.
European Journal of Immunology
|
May 22, 2008
IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
David Polchert, Justin Sobinsky, Gw Douglas, et al.
Journal of Viral Hepatitis
|
July 23, 2009
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B
R G Gish, T-T Chang, C-L Lai, et al.
Radiation Research
|
November 16, 2018
Specific Members of the Gut Microbiota are Reliable Biomarkers of Irradiation Intensity and Lethality in Large Animal Models of Human Health
Franck Carbonero, Alba Mayta, Mathilde Bolea, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine
|
June 16, 2000
HIV as a chronic disease: implications for long-term care at an AIDS-dedicated skilled nursing facility
P A Selwyn, J L Goulet, S Molde, et al.
The Journal of Infectious Diseases
|
May 1, 1996
Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia
B P Griffith, H Brett-Smith, G Kim, et al.
International Journal of Radiation Biology
|
September 10, 2020
The New Zealand white rabbit animal model of acute radiation syndrome: hematopoietic and coagulation-based parameters by radiation dose following supportive care
Andre Paredes, Matthew Lindeblad, Rachana Patil, et al.
Journal of Hepatology
|
December 17, 2008
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy
Daniel Shouval, Ching-Lung Lai, Ting-Tsung Chang, et al.
Journal of Viral Hepatitis
|
May 22, 2009
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B
T-T Chang, Y-C Chao, V V Gorbakov, et al.
AIDS (London, England)
|
August 30, 2008
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy
Mário Guimarães Pessôa, Brian Gazzard, Anna K Huang, et al.
Page
of 13